News ArticleAnupam Rasayan India Ltd. Updates Shareholders on US Acquisition and Pharma Expansion at 23rd AGM
Company detailed strategic growth initiatives and operational highlights for FY 2025-26 during the meeting held on September 30, 2026
Anupam Rasayan India Limited held its 23rd Annual General Meeting on September 30, 2026, via video conferencing. The company outlined its strategic progress for the fiscal year 2025-26 including the acquisition of Jayhawk Fine Chemicals Corporation in the US and a controlling stake in Bliss GVS Pharma Ltd. The AGM also featured participation details, board members, and key topics discussed, reflecting the company's focus on expanding its global specialty chemical and pharmaceutical presence.
Anupam Rasayan India Limited
General / Other
Anupam Rasayan India Limited conducted its 23rd Annual General Meeting on September 30, 2026, via video conferencing, discussing key corporate developments including its acquisition of Jayhawk Fine Chemicals Corporation in the US and expanding pharmaceutical business through a controlling stake in Bliss GVS Pharma Ltd.
The AGM was held in accordance with the Companies Act 2013 and the relevant regulations, with 38 members representing 58.56% of paid-up share capital attending virtually.
The meeting included presentations and introductions from Directors, Key Managerial Personnel (including CEO Gopal Agrawal, CFO Amit Khurana, and Company Secretary Ashish Gupta), and auditors participating remotely.
The Chairperson, Dr. Kiran Patel, highlighted the company’s growth strategy focusing on global integration, capability expansion, and technology enhancement in the specialty chemicals sector.
Key developments discussed included the company's acquisition of Jayhawk Fine Chemicals Corporation in the United States, establishing manufacturing presence in a major global chemical market.
Anupam Rasayan also acquired a controlling stake in Bliss GVS Pharma Ltd., aiming to strengthen its footprint in pharmaceuticals and leverage synergistic benefits in chemical and pharma domains.
Highlights
- 23rd Annual General Meeting held on September 30, 2026 via video conferencing.
- 38 members present representing 58.56% share capital.
- Acquisition of Jayhawk Fine Chemicals Corporation, USA.
- Controlling stake acquired in Bliss GVS Pharma Ltd.
- Focus on expanding specialty chemicals and pharmaceutical capabilities globally.
- Compliance with Companies Act 2013 and applicable MCA and SEBI regulations during AGM procedures.
Key Data Snapshot
What happened
- Anupam Rasayan India Limited conducted its 23rd Annual General Meeting on September 30, 2026, entirely virtually.
- The meeting was attended by board members, key managerial personnel, statutory auditors, and shareholders via video conferencing.
- The Chairperson presented key achievements and strategic initiatives for the fiscal year 2025-26, including significant acquisitions.
Key details
- The AGM was conducted in compliance with the Companies Act, 2013 and related MCA and SEBI circulars.
- Remote e-voting was made available from September 27 to 29, 2026, with additional voting facility at the AGM.
- Registers like Directors and KMP shareholding, contracts, and ESOP plan documents were available electronically for member inspection during the meeting.
Strategic context
- Acquisition of Jayhawk Fine Chemicals Corporation gives the company manufacturing presence in a major global chemical market (United States).
- Acquisition of controlling stake in Bliss GVS Pharma Ltd. will expand the company’s footprint in pharmaceuticals.
- Chairperson emphasized expansion via technology base enhancement and strengthening global supply chain participation.
Regulatory and governance context
- Meeting held fully compliant with relevant Indian corporate and securities regulations.
- Quorum included members and authorized representatives attending virtually, satisfying statutory requirements.
- Annual report and related documents were circulated electronically and made accessible on the company website and stock exchange platforms.
Highlights
- 23rd Annual General Meeting held on September 30, 2026 via video conferencing.
- 38 members present representing 58.56% share capital.
- Acquisition of Jayhawk Fine Chemicals Corporation, USA.
- Controlling stake acquired in Bliss GVS Pharma Ltd.
- Focus on expanding specialty chemicals and pharmaceutical capabilities globally.
- Compliance with Companies Act 2013 and applicable MCA and SEBI regulations during AGM procedures.
Disclosures
- Companies Act, 2013
- MCA circulars regarding virtual meetings
- SEBI circulars for listed companies
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
Ambuja Cements Posts Rs 9,197 Cr Revenue with 16.5 MnT Cement Sales in Q2 FY27, Trade and Premium Mix Advance
Ambuja Cements Limited reported consolidated cement sales of 16.5 million tonnes and revenue from operations of Rs 9,197 crore for the quarter ended September 30, 2026. The company grew trade volumes by 8.6% year-on-year with premium products rising to 37% of trade sales, and maintained an EBITDA margin of 13.8%.
Read Full Story
APAR Industries Reports Rs 914.80 Crore Half-Year Profit and USD 100 Million Investment Approval in Singapore Subsidiary
APAR Industries Limited released its un-audited financial results for the second quarter and half-year ended September 30, 2026, reporting a consolidated profit after tax of Rs 914.80 crore for the half-year. The Board also approved a capital investment of up to USD 100 million in its wholly owned Singapore subsidiary, Petroleum Specialties Pte Ltd.
Read Full Story
Union Bank of India Notifies Investors of Special Window for Physical Shares Transfer Requests Relodgement
Union Bank of India has announced a special window for the relodgement of transfer requests of physical shares to better serve investors and shareholders.
Read Full Story
